Дело C-432/25: Dr. August Wolff/EUIPO, Определение от 2 декември 2025 г.

Текст

... ure of the Court of Justice – Request failing to demonstrate that an issue is significant with respect to the unity, consistency or development of EU law – Refusal to allow the appeal to proceed )

In Case C‑432/25 P,

APPEAL under Article 56 of the Statute of the Court of Justice of the European Union, brought on 30 June 2025,

Dr. August Wolff GmbH & Co. KG Arzneimittel, established in Bielefeld (Germany), represented by M. Breuer and F. von der Decken, Rechtsanwälte,

appellant,

the other parties to the proceedings being:

European Union Intellectual Property Office (EUIPO),

defendant at first instance,

Combe International LLC, established in New York (United States),

intervener at first instance,

THE COURT (Chamber determining whether appeals may proceed),

composed of T. von Danwitz, Vice-President of the Court, S. Rodin and N. Piçarra (Rapporteur), Judges,

Registrar: A. Calot Escobar,

having regard to the proposal from the Judge-Rapporteur and after hearing the Advocate General, A. Rantos,

makes the following

Order

1. By its appeal, Dr. August Wolff GmbH & Co. KG Arzneimittel seeks to have set aside the judgment of the General Court of the European Union of 30 April 2025, Dr. August Wolff v EUIPO – Combe International (Vagisan) (T‑679/20, ‘the judgment under appeal’, EU:T:2025:421), by which the General Court dismissed its action for annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 3 September 2020 (Case R 2459/2019-4) relating to invalidity proceedings brought by Combe International ...